| 标题 |
Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis |
| 网址 | |
| DOI | |
| 其它 |
期刊:Current Medical Research and Opinion 作者:Alpesh Amin; Allison Keshishian; Dionne M. Hines; Oluwaseyi Dina; Hannah Le; et al 出版日期:2022-08-22 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)